Can Greggs shares grow my ISA like its sausage rolls enlarge my waistline?

Greggs’ shares surged earlier this week on the news that its pizza boxes and macaroni cheese had lifted sales. Dr James Fox remains cautious.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.

Image source: Getty Images

Greggs (LSE:GRG) shares jumped 7% in trading on Tuesday (20 May) after reporting its Q1 results. The push upwards indicates that the market was largely impressed by the company’s performance.

Greggs reported a 7.4% increase in sales for the first 20 weeks of the year. That suggests business was picking up after a slow start. However, much of this increase was driven by a rising store count — reaching 2,638.

A close look at the results shows that, on a like-for-like basis, sales were up just 2.9%. However, Greggs is currently anticipating cost inflation to be around 6% on a like-for-like basis for the year. 

All-in-all, I’m not seeing much to entice me to buy the stock. What’s more, there’s something in the company’s recent narrative that’s a little unconvincing.

It had previously pointed to poor weather conditions as the reasoning for its slow start to the year. But in the latest trading update, the firm pointed to a strong contribution from product innovations. That’s despite the weather really improving since March.

For context, like-for-like sales in company-managed shops increased 1.7% year-on-year in the first nine weeks of 2025, when poor weather dented footfall.

Still value for money?

Greggs’ forward price-to-earnings (P/E) ratios are projected at 16.2 times for 2025, 15.7 for 2026, and 15 for 2027. This tells us the shares trade at a premium to the index average.

Despite a rising dividend (yielding 3.14% in 2025 and 3.46% in 2027), the dividend-adjusted price-to-earnings-to-growth ratios remain elevated — around 1.8 — indicating limited earnings growth relative to valuation.

Net debt’s also rising, from £366.4m in 2025 to £375.8m in 2026, before easing to £341.8m in 2027. For me, Greggs appears overvalued on a dividend-adjusted growth basis. That’s based on the metrics and not my broader concerns about the company’s positioning.

As noted, much of Q1 growth was powered by aggressive store expansion, with plans for 140-150 net new openings in 2025 alone. This strategy, while effective for now, has natural limits. There are only so many viable sites in the UK, and such rapid expansion cannot continue indefinitely. 

Attempts to expand internationally haven’t succeeded in the past, and I’d suggest the product positioning would struggle to be anymore more than a niche offer in Europe or the US.

Personally, I’m also concerned about the durability and longevity of the baked goods market. While affordable, widespread and frequent consumption has an impact on the health of the nation. And while our waistlines are being attacked by Mounjaro and Wegovy, one day regulation and taxation could be the weapons of choice.

We have a fairly low bar for healthy foods in the UK, but I think that tells us just how much tastes can change. I’d argue that in an increasingly health-conscious nation, with slowly improving living standards, brands like Greggs will lose out in the long run.

It’s not a stock I’m looking to buy right now.

James Fox has no position in any of the shares mentioned. The Motley Fool UK has recommended Greggs Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »